Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005681 | spliceosomal complex | 3 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q7W6
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0030627 | pre-mRNA 5'-splice site binding | 6 | 2 |
GO:0036002 | pre-mRNA binding | 5 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 250 | 254 | PF00656 | 0.397 |
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.427 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.442 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.449 |
CLV_PCSK_FUR_1 | 85 | 89 | PF00082 | 0.440 |
CLV_PCSK_KEX2_1 | 269 | 271 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.426 |
CLV_PCSK_PC1ET2_1 | 269 | 271 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 87 | 89 | PF00082 | 0.432 |
CLV_PCSK_PC7_1 | 41 | 47 | PF00082 | 0.408 |
CLV_PCSK_PC7_1 | 81 | 87 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.417 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.516 |
CLV_PCSK_SKI1_1 | 373 | 377 | PF00082 | 0.390 |
DEG_APCC_DBOX_1 | 108 | 116 | PF00400 | 0.415 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.416 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.412 |
DEG_SPOP_SBC_1 | 130 | 134 | PF00917 | 0.537 |
DOC_ANK_TNKS_1 | 67 | 74 | PF00023 | 0.410 |
DOC_CDC14_PxL_1 | 30 | 38 | PF14671 | 0.392 |
DOC_CYCLIN_RxL_1 | 103 | 117 | PF00134 | 0.397 |
DOC_CYCLIN_yCln2_LP_2 | 107 | 113 | PF00134 | 0.416 |
DOC_CYCLIN_yCln2_LP_2 | 31 | 37 | PF00134 | 0.409 |
DOC_CYCLIN_yCln2_LP_2 | 4 | 10 | PF00134 | 0.410 |
DOC_MAPK_DCC_7 | 103 | 113 | PF00069 | 0.398 |
DOC_MAPK_DCC_7 | 9 | 17 | PF00069 | 0.412 |
DOC_MAPK_gen_1 | 269 | 280 | PF00069 | 0.438 |
DOC_MAPK_gen_1 | 45 | 51 | PF00069 | 0.416 |
DOC_MAPK_MEF2A_6 | 273 | 282 | PF00069 | 0.331 |
DOC_MAPK_MEF2A_6 | 417 | 426 | PF00069 | 0.436 |
DOC_MAPK_MEF2A_6 | 9 | 17 | PF00069 | 0.412 |
DOC_PP1_RVXF_1 | 107 | 114 | PF00149 | 0.398 |
DOC_PP1_RVXF_1 | 12 | 18 | PF00149 | 0.411 |
DOC_PP2B_LxvP_1 | 105 | 108 | PF13499 | 0.397 |
DOC_PP2B_LxvP_1 | 31 | 34 | PF13499 | 0.391 |
DOC_PP2B_LxvP_1 | 4 | 7 | PF13499 | 0.407 |
DOC_USP7_MATH_1 | 283 | 287 | PF00917 | 0.359 |
DOC_USP7_UBL2_3 | 269 | 273 | PF12436 | 0.473 |
LIG_14-3-3_CanoR_1 | 103 | 108 | PF00244 | 0.415 |
LIG_14-3-3_CanoR_1 | 20 | 24 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 336 | 341 | PF00244 | 0.488 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 58 | 65 | PF00244 | 0.420 |
LIG_14-3-3_CanoR_1 | 75 | 79 | PF00244 | 0.486 |
LIG_Actin_WH2_2 | 214 | 230 | PF00022 | 0.501 |
LIG_BIR_III_4 | 70 | 74 | PF00653 | 0.427 |
LIG_BRCT_BRCA1_1 | 253 | 257 | PF00533 | 0.432 |
LIG_BRCT_BRCA1_1 | 26 | 30 | PF00533 | 0.414 |
LIG_CSL_BTD_1 | 380 | 383 | PF09270 | 0.500 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.396 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.423 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.500 |
LIG_FHA_1 | 324 | 330 | PF00498 | 0.417 |
LIG_FHA_1 | 343 | 349 | PF00498 | 0.239 |
LIG_FHA_1 | 408 | 414 | PF00498 | 0.387 |
LIG_FHA_2 | 215 | 221 | PF00498 | 0.474 |
LIG_FHA_2 | 248 | 254 | PF00498 | 0.379 |
LIG_LIR_Gen_1 | 27 | 38 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 289 | 299 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 351 | 362 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 289 | 295 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.360 |
LIG_LYPXL_S_1 | 4 | 8 | PF13949 | 0.410 |
LIG_Pex14_1 | 95 | 99 | PF04695 | 0.398 |
LIG_SH2_GRB2like | 144 | 147 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 263 | 266 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 432 | 435 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.383 |
LIG_SH3_3 | 12 | 18 | PF00018 | 0.397 |
LIG_SH3_3 | 385 | 391 | PF00018 | 0.457 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.410 |
LIG_SUMO_SIM_anti_2 | 22 | 27 | PF11976 | 0.416 |
LIG_SUMO_SIM_par_1 | 22 | 27 | PF11976 | 0.416 |
LIG_SUMO_SIM_par_1 | 396 | 401 | PF11976 | 0.439 |
LIG_TRFH_1 | 30 | 34 | PF08558 | 0.411 |
LIG_WRPW_2 | 8 | 11 | PF00400 | 0.415 |
LIG_WW_3 | 11 | 15 | PF00397 | 0.411 |
MOD_CK1_1 | 114 | 120 | PF00069 | 0.393 |
MOD_CK1_1 | 134 | 140 | PF00069 | 0.564 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.440 |
MOD_CK1_1 | 286 | 292 | PF00069 | 0.418 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.499 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.527 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.471 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.541 |
MOD_GlcNHglycan | 342 | 345 | PF01048 | 0.533 |
MOD_GlcNHglycan | 391 | 394 | PF01048 | 0.477 |
MOD_GlcNHglycan | 400 | 403 | PF01048 | 0.493 |
MOD_GlcNHglycan | 419 | 422 | PF01048 | 0.375 |
MOD_GlcNHglycan | 435 | 438 | PF01048 | 0.251 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.618 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.470 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.434 |
MOD_GSK3_1 | 282 | 289 | PF00069 | 0.357 |
MOD_GSK3_1 | 305 | 312 | PF00069 | 0.412 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.464 |
MOD_GSK3_1 | 336 | 343 | PF00069 | 0.269 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.437 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.414 |
MOD_N-GLC_1 | 422 | 427 | PF02516 | 0.436 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.595 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.546 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.429 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.426 |
MOD_NEK2_1 | 342 | 347 | PF00069 | 0.402 |
MOD_NEK2_1 | 422 | 427 | PF00069 | 0.436 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.426 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.421 |
MOD_OFUCOSY | 21 | 28 | PF10250 | 0.397 |
MOD_PIKK_1 | 121 | 127 | PF00454 | 0.382 |
MOD_PIKK_1 | 348 | 354 | PF00454 | 0.467 |
MOD_PIKK_1 | 57 | 63 | PF00454 | 0.410 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.416 |
MOD_PKA_2 | 251 | 257 | PF00069 | 0.444 |
MOD_PKA_2 | 57 | 63 | PF00069 | 0.426 |
MOD_PKA_2 | 74 | 80 | PF00069 | 0.480 |
MOD_PKB_1 | 226 | 234 | PF00069 | 0.480 |
MOD_Plk_1 | 422 | 428 | PF00069 | 0.480 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.500 |
MOD_Plk_4 | 19 | 25 | PF00069 | 0.416 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.415 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.421 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.401 |
MOD_Plk_4 | 324 | 330 | PF00069 | 0.352 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.460 |
TRG_DiLeu_BaEn_1 | 372 | 377 | PF01217 | 0.535 |
TRG_DiLeu_BaLyEn_6 | 107 | 112 | PF01217 | 0.398 |
TRG_DiLeu_BaLyEn_6 | 31 | 36 | PF01217 | 0.410 |
TRG_DiLeu_BaLyEn_6 | 358 | 363 | PF01217 | 0.410 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.398 |
TRG_ER_diArg_1 | 44 | 46 | PF00400 | 0.438 |
TRG_ER_diArg_1 | 84 | 86 | PF00400 | 0.454 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5J8 | Leptomonas seymouri | 63% | 100% |
A0A1X0NQJ3 | Trypanosomatidae | 34% | 100% |
A0A3S7X1X9 | Leishmania donovani | 90% | 100% |
A0A422NG23 | Trypanosoma rangeli | 37% | 100% |
A4HGZ9 | Leishmania braziliensis | 87% | 100% |
A4I431 | Leishmania infantum | 93% | 100% |
E9B0B8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
O94620 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |